Independent fund research. Built on SEC filings.

How we research funds

Mutual fund · Allocation / Balanced · Gmo

GMO Asset Allocation Bond Fund Class III (GMOBX)

Ticker GMOBX · · Holdings as of May 31, 2026

Expense ratio
0.46%$46/yr per $10k
Net assets
$117.7Mall share classes
Holdings
12

Bottom line

Is GMOBX a good fund? The bottom line

GMOBX is the Class III share class of GMO Asset Allocation Bond Fund, an actively managed allocation / balanced mutual fund from Gmo.

Annual fees run 0.46% — about $46 a year on every $10,000 invested, cheaper than 90% of allocation / balanced funds we track.

With $118 million in net assets and 12 holdings, its largest position is Nomura Fixed Income Securities Private Ltd. (90.0%) and the top 10 make up 101.2% of the portfolio.

What stands out

  • Low cost: cheaper than 90% of allocation / balanced peers

What to watch

  • Concentrated: top 10 holdings are 101.2% of assets

Updated Nov 19, 2026

What GMOBX invests in

Total return in excess of that of its benchmark, the FTSE 3-Month Treasury Bill Index.

The investment strategies GMO pursues for the Fund are intended to complement the strategies it is pursuing for GMO Global Asset Allocation Fund and other funds and accounts it manages. Accordingly, the Fund is not intended to serve as a standalone investment. The Fund invests in a portfolio of fixed income instruments of varying maturities, which may be represented by bonds, forward contracts or derivatives such as options, futures contracts, or swap agreements. GMO uses a variety of fundamental and quantitative processes to manage the Fund. GMO evaluates the relative attractiveness of particular markets and instruments using various fixed income risk premium measures, which typically include, among others, term structure, foreign exchange, volatility, credit, and liquidity. Under normal circumstances, the Fund invests directly and indirectly (e.g., through other GMO Funds or…

From the fund's prospectus (filed Oct 20, 2026).

What GMOBX costs

On a $10,000 investment, GMOBX's 0.46% expense ratio costs about $46 a year. The prospectus estimates $903 in total costs over 10 years (assuming 5% annual returns). The median allocation / balanced fund charges 0.91%.

See the full GMOBX fee table →

GMOBX top 10 holdings

#Holding% of fund
1Nomura Fixed Income Securities Private Ltd.90.04%
2United States Treasury4.13%
3United States Treasury3.76%
4State Street Global Advisors2.16%
5Chicago Board of Trade0.31%
6Chicago Board of Trade0.29%
7Chicago Board of Trade0.28%
8Chicago Board of Trade0.10%
9Chicago Board of Trade0.08%
10Chicago Board of Trade0.06%

Source: SEC Form N-PORT, period ended May 31, 2026

The top 10 make up 101.2% of the fund. See all top 25 holdings and asset mix →

Alternatives to GMOBX

More funds like GMOBX →

GMOBX FAQ

What is the expense ratio of GMOBX?
GMOBX's expense ratio is 0.46%, which works out to about $46 a year for every $10,000 invested. The prospectus estimates total costs of $903 over 10 years on a $10,000 investment (assuming 5% annual returns).
Is GMOBX a good investment?
It depends on your goals, but the data points to: low cost: cheaper than 90% of allocation / balanced peers; concentrated: top 10 holdings are 101.2% of assets. This is general information, not personalized advice.
What does GMOBX hold?
GMOBX's largest holdings are Nomura Fixed Income Securities Private Ltd. (90.0%), United States Treasury (4.1%), United States Treasury (3.8%), State Street Global Advisors (2.2%), Chicago Board of Trade (0.3%). It holds 12 positions in total as of May 31, 2026 (SEC Form N-PORT).
Who manages GMOBX?
GMOBX is offered by Gmo through Gmo Trust.